Skip to main content
. 2022 Jun 20;54(1):1686–1700. doi: 10.1080/07853890.2022.2085881

Table 5.

Pharmacokinetic parameters of tetracycline-class drugs [8–13,47].

Antibiotic Maintenance dose Dosing frequency Food effect (Cmax decrease) Protein binding Half-life Metabolism Excretion
Tetracycline Oral: 250/500 mg Oral: BID to QID 50% 55–64% 6–11 h Yes Fecal: 20–60%
Renal: 30%
Doxycycline IV: 100 mg
Oral: 100 mg
Oral: QD or BID
IV: BID
20%   12–25 h Yes Renal: 40%
Minocycline IV: 100 mg
Oral: 50/75/100 mg
Oral: BID 76% 11–24 h Yes Fecal: 20–35%
Renal: 5–12%
Omadacycline IV: 100 mg
Oral: 300 mg
Oral: QD
IV: QD
40–59% 20% 16 h Yes Fecal (oral): 81%
Renal (IV/oral): 27%/14%
Tigecycline IV: 50 mg IV: BID NA 71–89% 42 h None Biliary/Fecal: 59%
Renal: 33%
Eravacycline IV: 1 mg/kg IV: BID NA 79–90% 20 h CYP3A4- and FMO-mediated oxidation Biliary/Fecal: 47%
Renal: 34%

BID: twice daily; IV: intravenous; NA: not applicable; QD: daily; QID: four times daily.